BElumosudil for Bronchiolitis Obliterans Prevention/Therapy (BEBOP)
Conditions:   Bronchiolitis Obliterans Syndrome;   Bronchiolitis Obliterans;   Lung Diseases;   Chronic Graft Versus Host Disease Interventions:   Drug: Belumosudil;   Drug: Fluticasone;   Drug: Azithromycin;   Drug: Prednisone Sponsors:   Dana-Farber Cancer Institute;   Sanofi;   National Heart, Lung, and Blood Institute (NHLBI) Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 28, 2023 Category: Research Source Type: clinical trials

BElumosudil for Bronchiolitis Obliterans Prevention/Therapy (BEBOP)
Conditions:   Bronchiolitis Obliterans Syndrome;   Bronchiolitis Obliterans;   Lung Diseases;   Chronic Graft Versus Host Disease Interventions:   Drug: Belumosudil;   Drug: Fluticasone;   Drug: Azithromycin;   Drug: Prednisone;   Drug: Montelukast Sponsors:   Dana-Farber Cancer Institute;   Sanofi;   National Heart, Lung, and Blood Institute (NHLBI) Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 28, 2023 Category: Research Source Type: clinical trials